Skip to content

Pharminent

cropped-neurology_aaic_banner_frontpage_2026-07-15-1.png
Primary Menu
  • Home
  • Signal News
  • Biopharma Brief
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Interactive Calendar
    • Manufacturing Intelligence
  • Contact
Light/Dark Button
Brief
  • Home
  • Other
  • UK Knowledge Quarter welcomes Boehringer Ingelheim AI accelerator
  • Other

UK Knowledge Quarter welcomes Boehringer Ingelheim AI accelerator

Pharmaphorum

Boehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI ML in the UK.

OtherRead full story

pharminent April 20, 2026 (Last updated: April 20, 2026)

Pharmaphorum

Boehringer Ingelheim has announced expansion of its global Computational Innovation footprint with a new centre dedicated to AI ML in the UK.

OtherRead full story

Post navigation

Previous: Update: Lilly makes $7bn bid for in vivo CAR-T firm Kelonia
Next: FDA Policy Tracker 2026: Psychedelics get a boost

Related Stories

  • Other

ASCO ’26: Bispecifics vs. ADCs, a ‘RAS’ revolution and a step change in prostate cancer

pharminent June 2, 2026
  • Other

ASCO26: Symptom-tracking app helps advanced cancer patients

pharminent June 2, 2026
  • Other

All eyes on Revolution, bispecific antibodies and more at ASCO26

pharminent May 26, 2026
© 2026 All rights reserved. | ReviewNews by AF themes.